| Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape NI Mazur, J Terstappen, R Baral, A Bardají, P Beutels, UJ Buchholz, ... The Lancet Infectious Diseases 23 (1), e2-e21, 2023 | 299 | 2023 |
| Demographic and clinical features as predictors of clozapine response in patients with schizophrenia spectrum disorders: a systematic review and meta-analysis C Okhuijsen-Pfeifer, AY Sterk, IM Horn, J Terstappen, RS Kahn, JJ Luykx Neuroscience & Biobehavioral Reviews 111, 246-252, 2020 | 38 | 2020 |
| Access to highly effective long-acting RSV-monoclonal antibodies for children in LMICs—reducing global inequity HJ Zar, M Piccolis, J Terstappen, NI Mazur, L Gaayeb, S Morin, L Bont The Lancet Global Health 12 (10), e1582-e1583, 2024 | 4 | 2024 |
| RSV neutralizing antibodies in dried blood J Terstappen, EM Delemarre, A Versnel, JT White, A Derrien-Colemyn, ... The Journal of infectious diseases 230 (1), e93-e101, 2024 | 4 | 2024 |
| The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access J Terstappen, SF Hak, A Bhan, D Bogaert, LJ Bont, UJ Buchholz, ... The Lancet Infectious Diseases, 2024 | 4 | 2024 |
| Daily intranasal palivizumab to prevent respiratory syncytial virus infection in healthy preterm infants: a phase 1/2b randomized placebo-controlled trial NI Mazur, YN Löwensteyn, J Terstappen, J Leusen, F Schobben, D Cianci, ... EClinicalMedicine 66, 2023 | 3 | 2023 |
| RSM01, a novel respiratory syncytial virus monoclonal antibody: preclinical characterization and results of a first-in-human, randomised clinical trial A Bonavia, M Levi, H Rouha, A Badarau, J Terstappen, S Watson, ... BMC Infectious Diseases 24 (1), 1-18, 2024 | 1 | 2024 |
| Replacing serum with dried blood microsampling for pharmacokinetics, viral neutralisation and immunogenicity bioanalysis supporting future paediatric development of RSM01, a … JT White, J Terstappen, M Levi, A Radivojevic, R Noble, AB Anderson, ... BMC Infectious Diseases 24 (1), 1403, 2024 | | 2024 |
| Small molecule-directed differentiation of submerged-cultured human nasal airway epithelia for respiratory disease modelling HHM Dreyer, GN Ithakisiou, S Spelier, MK Iwanski, E Katrukha, ... bioRxiv, 2024.10. 17.618953, 2024 | | 2024 |
| Technology transfer of a dried blood virus neutralization assay to a GAVI-eligible country. E Obodai, J Terstappen, JY Mensah, A Versnel, CN Antwi, LJ Bont, ... medRxiv, 2024.07. 23.24310857, 2024 | | 2024 |
